Latest Breaking News On - Alimera sciences - Page 2 : comparemela.com

Alimera Sciences (ALIM) Buy Rating Reaffirmed at HC Wainwright

Alimera Sciences (ALIM) Buy Rating Reaffirmed at HC Wainwright
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesVanguard group incAlimera sciences company profileWorth venture partnersAlimera sciencesHillsdale investment management incAlimera sciences incAlimera sciences price performanceNews ratings for alimera sciences dailyInstitutional trading of alimera sciencesMaxim groupAncora advisorsFree reportGet free reportLane capitalInvestment management

Uveitis Treatment Market and Competitive Landscape Report,

Dublin, May 16, 2024 (GLOBE NEWSWIRE) The

United statesAsia pacificAlimera sciencesBausch healthEyepoint pharmaceuticalsDrug stores retail pharmaciesList of uveitis treatment companiesPorter fiveTreatment market reportCompetitive analysisTreatment marketDrug classDisease typeDistribution channelUveitis treatmentSize estimates

Alimera Sciences Reports Q1 Loss, Misses Revenue Estimates - Alimera Sciences (NASDAQ:ALIM), Ovid Therapeutics (NASDAQ:OVID)

Alimera Sciences Reports Q1 Loss, Misses Revenue Estimates - Alimera Sciences (NASDAQ:ALIM), Ovid Therapeutics (NASDAQ:OVID)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Ovid therapeuticsAlimera sciencesWhile alimera sciencesZacks consensus estimateZacks medicalZacks rankZacks industry rank

Alimera Sciences Reports Q1 Loss, Misses Revenue Estimates

Alimera Sciences Reports Q1 Loss, Misses Revenue Estimates
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Alimera sciencesZacks consensus estimate

EyePoint reports Duravyu trial fail, raising questions

EyePoint reports Duravyu trial fail, raising questions
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Eyepoint duravyuGraig suvannavejhAlimera sciencesBetta pharmaceuticalsEyepoint pharmaceuticalsDiabetic retinopathy severity scaleEquinox scienceChina approved yutiq